The effectiveness of the Liverpool care pathway in improving end of life care for dying cancer patients in hospital. A cluster randomised trial

por Costantini, Massimo, Ottonelli, Simona, Canavacci, Laura, Pellegrini, Fabio, Beccaro, Monica
Publicado 2011

Decision Curve Analysis for Personalized Treatment Choice between Multiple Options

por Chalkou, Konstantina, Vickers, Andrew J., Pellegrini, Fabio, Manca, Andrea, Salanti, Georgia
Publicado 2022

A two‐stage prediction model for heterogeneous effects of treatments

por Chalkou, Konstantina, Steyerberg, Ewout, Egger, Matthias, Manca, Andrea, Pellegrini, Fabio, Salanti, Georgia
Publicado 2021

Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

por Franciosi, Monica, Lucisano, Giuseppe, Lapice, Emanuela, Strippoli, Giovanni F. M., Pellegrini, Fabio, Nicolucci, Antonio
Publicado 2013

Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry

por Braune, Stefan, Grimm, Sarah, van Hövell, Philip, Freudensprung, Ulrich, Pellegrini, Fabio, Hyde, Robert, Bergmann, Arnfin
Publicado 2018

On the aggregation of published prognostic scores for causal inference in observational studies

por Nguyen, Tri‐Long, Collins, Gary S., Pellegrini, Fabio, Moons, Karel G.M., Debray, Thomas P.A.
Publicado 2020

The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review

por Karim, Mohammad Ehsanul, Pellegrini, Fabio, Platt, Robert W, Simoneau, Gabrielle, Rouette, Julie, de Moor, Carl
Publicado 2020

Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP)

por Wiendl, Heinz, Butzkueven, Helmut, Kappos, Ludwig, Trojano, Maria, Pellegrini, Fabio, Paes, Dominic, Zhang, Annie, Belachew, Shibeshih
Publicado 2016

Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in multiple sclerosis

por Debray, Thomas PA, Simoneau, Gabrielle, Copetti, Massimiliano, Platt, Robert W, Shen, Changyu, Pellegrini, Fabio, de Moor, Carl
Publicado 2023

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

por De Berardis, Giorgia, Sacco, Michele, Strippoli, Giovanni F M, Pellegrini, Fabio, Graziano, Giusi, Tognoni, Gianni, Nicolucci, Antonio
Publicado 2009

Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT

por De Cosmo, Salvatore, Motterlini, Nicola, Prudente, Sabrina, Pellegrini, Fabio, Trevisan, Roberto, Bossi, Antonio, Remuzzi, Giuseppe, Trischitta, Vincenzo, Ruggenenti, Piero
Publicado 2009

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

por Butzkueven, Helmut, Kappos, Ludwig, Pellegrini, Fabio, Trojano, Maria, Wiendl, Heinz, Patel, Radhika N, Zhang, Annie, Hotermans, Christophe, Belachew, Shibeshih
Publicado 2014

Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials

por Palmer, Suetonia C., Nistor, Ionut, Craig, Jonathan C., Pellegrini, Fabio, Messa, Piergiorgio, Tonelli, Marcello, Covic, Adrian, Strippoli, Giovanni F. M.
Publicado 2013

Benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study: protocol, tools, and population

por Nicolucci, Antonio, Rossi, Maria C, Pellegrini, Fabio, Lucisano, Giuseppe, Pintaudi, Basilio, Gentile, Sandro, Marra, Giampiero, Skovlund, Soren E, Vespasiani, Giacomo
Publicado 2014

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

por Kappos, Ludwig, Butzkueven, Helmut, Wiendl, Heinz, Spelman, Timothy, Pellegrini, Fabio, Chen, Yi, Dong, Qunming, Koendgen, Harold, Belachew, Shibeshih, Trojano, Maria
Publicado 2017

Role of the ENPP1 K121Q Polymorphism in Glucose Homeostasis

por Baratta, Roberto, Rossetti, Paola, Prudente, Sabrina, Barbetti, Fabrizio, Sudano, Dora, Nigro, Angela, Farina, Maria Grazia, Pellegrini, Fabio, Trischitta, Vincenzo, Frittitta, Lucia
Publicado 2008

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease

por Paroni, Giulia, Seripa, Davide, Fontana, Andrea, D’Onofrio, Grazia, Gravina, Carolina, Urbano, Maria, Cascavilla, Leandro, Pellegrini, Fabio, Greco, Antonio, Pilotto, Alberto
Publicado 2014

Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques reg...

por Simoneau, Gabrielle, Jiang, Xiaotong, Rollot, Fabien, Tian, Lu, Copetti, Massimiliano, Guéry, Matthieu, Ruiz, Marta, Vukusic, Sandra, de Moor, Carl, Pellegrini, Fabio
Publicado 2022

Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis

por Fontana, Andrea, Spadaro, Sara, Copetti, Massimiliano, Spoto, Belinda, Salvemini, Lucia, Pizzini, Patrizia, Frittitta, Lucia, Mallamaci, Francesca, Pellegrini, Fabio, Trischitta, Vincenzo, Menzaghi, Claudia
Publicado 2015

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients

por Simone, Isabella Laura, Ceccarelli, Antonia, Tortorella, Carla, Bellacosa, Alessandra, Pellegrini, Fabio, Plasmati, Immacolata, De Caro, Maria Fara, Lopez, Mariangela, Girolamo, Francesco, Livrea, Paolo
Publicado 2006